Evidence map›Paper›PMID 39310256›Full record

Observational studyInternational journal of medical sciences2024

Using oral molecular hydrogen supplements to combat microinflammation in humans: a pilot observational study.

Kuo-Cheng Lu, Min-Chung Shen, Reui-Lin Wang, Wen-Wen Chen, Szu-Han Chiu, Yung-His Kao, Feng-Cheng Liu, Po-Jen Hsiao

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in International journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kuo-Cheng LuDivision of Nephrology, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Min-Chung ShenRheumatology/Immunology and Allergy, Department of Medicine, Armed Forces Taoyuan General Hospital, Taoyuan, Taiwan.
Reui-Lin WangDivision of Medicine, Armed Forces Taoyuan General Hospital, Taoyuan, Taiwan.
Wen-Wen ChenNursing Department, Min-Sheng General Hospital, Taoyuan, Taiwan.
Szu-Han ChiuDivision of Endocrinology and Metabolism, Department of Medicine, Armed Forces Taoyuan General Hospital, Taoyuan, Taiwan.
Yung-His KaoDepartment of Life Sciences, National Central University, Taoyuan, Taiwan.
Feng-Cheng LiuRheumatology/Immunology and Allergy, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Po-Jen HsiaoDivision of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dietary SupplementsHydrogenInflammationAdministration, OralAdultAgedAnti-Inflammatory AgentsAntioxidantsBlood SedimentationC-Reactive ProteinFemaleHumansMaleMiddle AgedOxidative StressPilot ProjectsAnti-Inflammatory AgentsAntioxidantsC-Reactive ProteinHydrogenReactive Oxygen Speciesanti-inflammatory effectsantioxidantchronic diseaseschronic inflammationmolecular hydrogen, oral solid hydrogen capsules (OSHCs)

Identifiers

PMID39310256
PMCPMC11413900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.